Ann: Positive Results from IHL-675 (ARDS) animal study, page-128

My personal opinion is that our share price ended the day lower than expected due to investors putting their money elsewhere. They saw that there is still 5 weeks till potential FDA Emergency/Stage 2 news and don’t want to wait that long to jump on board. IMO they will revisit in a couple weeks before jumping on board which the SP will then begin to drive upwards.

The reason I believe this is a week prior to the announcement of stage 1, we saw a large increase in interest as people are expecting imminent news, and the SP continually jumped day on day.

I believe we can easily hit the teens in the next 2 weeks.

All IMO and DYOR